- Zacks•7 days ago
ResMed Inc. (RMD) is slated to report second-quarter fiscal 2017 results, after market close on Jan 23.
- PR Newswire•8 days ago
LONDON, Jan. 12, 2017 /PRNewswire/ -- ResMed (NYSE:RMD) today announced new European research from Price Waterhouse Coopers (PwC), revealing that patients with sleep apnea who use ResMed's myAir have greater ...
- TheStreet.com•9 days ago
The short trade is crowded in these four big stocks.
RMD : Summary for ResMed Inc. Common Stock - Yahoo Finance
ResMed Inc. (RMD)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||62.71 - 63.53|
|52 Week Range||53.28 - 70.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||25.67|
|Dividend & Yield||1.32 (2.09%)|
|1y Target Est||N/A|